Global Retirement Partners’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$52.1K Buy
4,530
+1,050
+30% +$16.2K ﹤0.01% 2323
2025
Q3
$84.6K Buy
3,480
+1,400
+67% +$23.3K ﹤0.01% 1593
2025
Q2
$34.2K Buy
+2,080
New +$35.9K ﹤0.01% 1980
2024
Q4
$73.5K Buy
1,980
+700
+55% +$26.8K ﹤0.01% 1428
2024
Q3
$41K Buy
1,280
+355
+38% +$19.7K ﹤0.01% 1656
2024
Q2
$75.9K Buy
+925
New +$100K ﹤0.01% 1329

Other funds holding CDLX

Global Retirement Partners's CDLX Position: Q4 2025 in Review

Global Retirement Partners increased its Cardlytics (CDLX) stake by 30% in Q4 2025, buying an estimated $16.2K and bringing the position to 4,530 shares worth $52.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Global Retirement Partners first reported a position in CDLX in Q2 2024 and has held it in 6 quarters since. The position peaked at $84.6K in Q3 2025. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • Global Retirement Partners held 4,530 shares of Cardlytics worth $52.1K as of Q4 2025.
  • Global Retirement Partners bought 1,050 Cardlytics shares in Q4 2025, an estimated $16.2K.
  • Cardlytics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2323 holding.
  • Global Retirement Partners first reported a position in Cardlytics in Q2 2024 and has held it in 6 quarters since.
  • Global Retirement Partners's Cardlytics position peaked at $84.6K in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.